miRNA Details
miRNA General Information | |||||
---|---|---|---|---|---|
miRNA Mature ID | hsa-miR-182-5p | ||||
miRNA Stemloop AC | MI0000272 | ||||
miRNA Stemloop ID | hsa-mir-182 | ||||
Sequence | uuuggcaaugguagaacucacacu | ||||
TTD Target(s) Regulated by This miRNA | Apoptosis regulator Bcl-2 (BCL-2) | Successful Target | Target Info | [1] | |
Retinoic acid receptor gamma (RARG) | Successful Target | Target Info | [2] | ||
Glycogen synthase kinase-3 beta (GSK-3B) | Clinical trial Target | Target Info | [3] | ||
Serine/threonine-protein kinase Chk2 (RAD53) | Clinical trial Target | Target Info | [4] | ||
Brain-derived neurotrophic factor (BDNF) | Clinical trial Target | Target Info | [5] | ||
Thrombospondin-1 (THBS1) | Clinical trial Target | Target Info | [6] | ||
Phospholipase D1 (PLD1) | Patented-recorded Target | Target Info | [7] | ||
Phosphatase and tensin homolog (PTEN) | Literature-reported Target | Target Info | [8] | ||
Cyclic AMP-responsive element-binding protein (CREB1) | Literature-reported Target | Target Info | [9] | ||
Forkhead box protein O1A (FOXO1) | Literature-reported Target | Target Info | [10] | ||
CDK inhibitor 1B p27Kip1 (CDKN1B) | Literature-reported Target | Target Info | [4] | ||
F-box and WD-40 domain protein 7 (Fbxw7) | Literature-reported Target | Target Info | [11] | ||
Melanoma differentiation-associated protein 6 (CDKN1A) | Literature-reported Target | Target Info | [12] | ||
T-lymphoma invasion and metastasis 1 (TIAM1) | Literature-reported Target | Target Info | [13] | ||
Tumor suppressor p53-binding protein 1 (TP53BP1) | Literature-reported Target | Target Info | [4] | ||
Neuritin (NRN1) | Literature-reported Target | Target Info | [14] | ||
Suppressor of tumorigenicity 15 protein (ST15) | Literature-reported Target | Target Info | [15] | ||
Protein(s) Regulated by This miRNA | Adenylate cyclase type 6 | Regulated Protein | [16] | ||
AN1-type zinc finger protein 4 | Regulated Protein | [17] | |||
Arrestin domain-containing protein 3 | Regulated Protein | [18] | |||
BRCA1-associated RING domain protein 1 | Regulated Protein | [4] | |||
Cell adhesion molecule 1 | Regulated Protein | [20] | |||
Cell cycle checkpoint protein RAD17 | Regulated Protein | [4] | |||
Circadian locomoter output cycles protein kaput | Regulated Protein | [21] | |||
Cullin-5 | Regulated Protein | [22] | |||
Cyclic AMP-dependent transcription factor ATF-1 | Regulated Protein | [4] | |||
Cyclic AMP-responsive element-binding protein 5 | Regulated Protein | [4] | |||
Cytochrome b-c1 complex subunit Rieske, mitochondrial | Regulated Protein | [23] | |||
DNA-binding protein SATB2 | Regulated Protein | [24] | |||
E3 ubiquitin-protein ligase TRIM8 | Regulated Protein | [25] | |||
Fibroblast growth factor 9 | Regulated Protein | [26] | |||
Flotillin-1 | Regulated Protein | [27] | |||
Forkhead box protein F2 | Regulated Protein | [28] | |||
Forkhead box protein O3 | Regulated Protein | [29] | |||
G1/S-specific cyclin-D2 | Regulated Protein | [1] | |||
Leucine-rich repeat-containing protein 4 | Regulated Protein | [31] | |||
Metastasis suppressor protein 1 | Regulated Protein | [32] | |||
Microphthalmia-associated transcription factor | Regulated Protein | [1] | |||
Microphthalmia-associated transcription factor | Regulated Protein | [16] | |||
Mothers against decapentaplegic homolog 4 | Regulated Protein | [33] | |||
Neural cell adhesion molecule L1-like protein | Regulated Protein | [34] | |||
Neurotrimin | Regulated Protein | [26] | |||
Profilin-1 | Regulated Protein | [35] | |||
Programmed cell death protein 4 | Regulated Protein | [36] | |||
Protein NDRG1 | Regulated Protein | [37] | |||
Protocadherin-8 | Regulated Protein | [38] | |||
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3 | Regulated Protein | [4] | |||
Transcription elongation factor A protein-like 7 | Regulated Protein | [39] | |||
TSC22 domain family protein 3 | Regulated Protein | [21] | |||
Tumor protein p53-inducible nuclear protein 1 | Regulated Protein | [40] | |||
Ubiquitin carboxyl-terminal hydrolase CYLD | Regulated Protein | [41] | |||
UL16-binding protein 2 | Regulated Protein | [42] | |||
Zinc finger protein SNAI2 | Regulated Protein | [43] | |||
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial | Regulated Protein | [44] | |||
References | |||||
REF 1 | Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2. PLoS One. 2012;7(7):e40967. | ||||
REF 2 | Alterations in microRNA expression in stress-induced cellular senescence. Mech Ageing Dev. 2009 Nov-Dec;130(11-12):731-41. | ||||
REF 3 | Glycogen synthase kinase 3 beta inhibits microRNA-183-96-182 cluster via the -Catenin/TCF/LEF-1 pathway in gastric cancer cells. Nucleic Acids Res. 2014 Mar;42(5):2988-98. | ||||
REF 4 | MicroRNA-182-5p targets a network of genes involved in DNA repair. RNA. 2013 Feb;19(2):230-42. | ||||
REF 5 | Alterations of serum levels of BDNF-related miRNAs in patients with depression. PLoS One. 2013 May 21;8(5):e63648. | ||||
REF 6 | Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense Expert Opin Ther Targets. 2013 Nov;17(11):1249-61. | ||||
REF 7 | A Repertoire of MicroRNAs Regulates Cancer Cell Starvation by Targeting Phospholipase D in a Feedback Loop That Operates Maximally in Cancer Cells. Mol Cell Biol. 2016 Jan 19;36(7):1078-89. | ||||
REF 8 | Elucidation of transcriptome-wide microRNA binding sites in human cardiac tissues by Ago2 HITS-CLIP. Nucleic Acids Res. 2016 Sep 6;44(15):7120-31. | ||||
REF 9 | MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma. FEBS J. 2012 Apr;279(7):1252-60. | ||||
REF 10 | Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem. 2009 Aug 28;284(35):23204-16. | ||||
REF 11 | Sequential expression of miR-182 and miR-503 cooperatively targets FBXW7, contributing to the malignant transformation of colon adenoma to adenocarcinoma. J Pathol. 2014 Dec;234(4):488-501. | ||||
REF 12 | Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3' untranslated region. Oncogene. 2010 Apr 15;29(15):2302-8. | ||||
REF 13 | The Downregulation of MiR-182 Is Associated with the Growth and Invasion of Osteosarcoma Cells through the Regulation of TIAM1 Expression. PLoS One. 2015 May 14;10(5):e0121175. | ||||
REF 14 | microRNA-182 inhibits the proliferation and migration of glioma cells through the induction of neuritin expression. Oncol Lett. 2015 Aug;10(2):1197-1203. | ||||
REF 15 | A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins. Nat Methods. 2011 May 15;8(7):559-64. | ||||
REF 16 | MicroRNA (miRNA) transcriptome of mouse retina and identification of a sensory organ-specific miRNA cluster.J Biol Chem. 2007 Aug 24;282(34):25053-66. | ||||
REF 17 | MicroRNA-182 inhibits proliferation through targeting oncogenic ANUBL1 in gastric cancer.Oncol Rep. 2015 Apr;33(4):1707-16. | ||||
REF 18 | Androgen receptor regulated microRNA miR-182-5p promotes prostate cancer progression by targeting the ARRDC3/ITGB4 pathway.Biochem Biophys Res Commun. 2016 May 20;474(1):213-219. | ||||
REF 19 | MicroRNA-182-5p targets a network of genes involved in DNA repair. RNA. 2013 Feb;19(2):230-42. | ||||
REF 20 | TGF- upregulates miR-182 expression to promote gallbladder cancer metastasis by targeting CADM1.Mol Biosyst. 2014 Mar 4;10(3):679-85. | ||||
REF 21 | Genetic variants and abnormal processing of pre-miR-182, a circadian clock modulator, in major depression patients with late insomnia.Hum Mol Genet. 2010 Oct 15;19(20):4017-25. | ||||
REF 22 | Cullin-5, a ubiquitin ligase scaffold protein, is significantly underexpressed in endometrial adenocarcinomas and is a target of miR-182.Oncol Rep. 2016 Apr;35(4):2461-5. | ||||
REF 23 | Knockdown of miR-182 promotes apoptosis via regulating RIP1 deubiquitination in TNF--treated triple-negative breast cancer cells. Tumour Biol. 2016 Oct;37(10):13733-13742. | ||||
REF 24 | microRNA-182 targets special AT-rich sequence-binding protein 2 to promote colorectal cancer proliferation and metastasis.J Transl Med. 2014 May 1;12:109. | ||||
REF 25 | miR-182 promotes tumor growth and increases chemoresistance of human anaplastic thyroid cancer by targeting tripartite motif 8.Onco Targets Ther. 2017 Feb 24;10:1115-1122. | ||||
REF 26 | miR-182 inhibits Schwann cell proliferation and migration by targeting FGF9 and NTM, respectively at an early stage following sciatic nerve injury.Nucleic Acids Res. 2012 Nov 1;40(20):10356-65. | ||||
REF 27 | Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway.Mol Cancer. 2014 May 17;13:109. | ||||
REF 28 | MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer. PLoS One. 2013;8(1):e55502. | ||||
REF 29 | Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor.Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1814-9. | ||||
REF 30 | Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2. PLoS One. 2012;7(7):e40967. | ||||
REF 31 | Disturbing miR-182 and -381 inhibits BRD7 transcription and glioma growth by directly targeting LRRC4.PLoS One. 2014 Jan 3;9(1):e84146. | ||||
REF 32 | MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma.J Pathol. 2012 Oct;228(2):204-15. | ||||
REF 33 | Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer. PLoS One. 2012;7(11):e51056. | ||||
REF 34 | miR-182 targets CHL1 and controls tumor growth and invasion in papillary thyroid carcinoma.Biochem Biophys Res Commun. 2014 Jul 18;450(1):857-62. | ||||
REF 35 | Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1.Tumour Biol. 2013 Jun;34(3):1713-22. | ||||
REF 36 | MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas.J Cell Biochem. 2013 Jul;114(7):1464-73. | ||||
REF 37 | Overexpressed microRNA-182 promotes proliferation and invasion in prostate cancer PC-3 cells by down-regulating N-myc downstream regulated gene 1 (NDRG1).PLoS One. 2013 Jul 16;8(7):e68982. | ||||
REF 38 | miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis.Cancer Res. 2016 Jul 15;76(14):4293-304. | ||||
REF 39 | MicroRNA-182 promotes tumor cell growth by targeting transcription elongation factor A-like 7 in endometrial carcinoma.Cell Physiol Biochem. 2013;32(3):581-90. | ||||
REF 40 | Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1.Gene. 2014 Apr 1;538(2):342-7. | ||||
REF 41 | TGF- induces miR-182 to sustain NF-B activation in glioma subsets.J Clin Invest. 2012 Oct;122(10):3563-78. | ||||
REF 42 | A novel recombinant Salmonella vaccine enhances the innate immunity of NK cells against acute myeloid leukaemia cells Kasumi-1 in vitro.Cell Biol Int. 2013 Dec;37(12):1320-9. | ||||
REF 43 | MiR-182 and miR-203 induce mesenchymal to epithelial transition and self-sufficiency of growth signals via repressing SNAI2 in prostate cells.Int J Cancer. 2013 Aug 1;133(3):544-55. | ||||
REF 44 | miR-182 Regulates Metabolic Homeostasis by Modulating Glucose Utilization in Muscle.Cell Rep. 2016 Jul 19;16(3):757-68. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.